Načítá se...

Current statuses of molecular targeted and immune checkpoint therapies in hepatocellular carcinoma

Treatment of advanced hepatocellular carcinoma (HCC) still confronts great challenges due to high rate of therapeutic resistance. The emergence of systemic treatment with molecular targeted and immune checkpoint therapies has brought novel approaches towards patients with advanced HCC. However, sora...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Cancer Res
Hlavní autoři: Kong, Deqiang, Liu, Chen, Miao, Xiaolong, Wang, Yao, Ding, Xianfeng, Gong, Weihua
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269783/
https://ncbi.nlm.nih.gov/pubmed/32509395
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!